Zepp Health Price to Sales Ratio 2017-2025 | ZEPP
Historical PS ratio values for Zepp Health (ZEPP) over the last 10 years. The current P/S ratio for Zepp Health as of November 06, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Zepp Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-11-06 | 27.73 | 2.22 | |
| 2025-06-30 | 2.66 | $12.46 | 0.21 |
| 2025-03-31 | 2.96 | $11.21 | 0.26 |
| 2024-12-31 | 2.60 | $11.27 | 0.23 |
| 2024-09-30 | 4.35 | $13.08 | 0.33 |
| 2024-06-30 | 2.40 | $15.64 | 0.15 |
| 2024-03-31 | 4.08 | $19.21 | 0.21 |
| 2023-12-31 | 5.68 | $22.79 | 0.25 |
| 2023-09-30 | 4.60 | $26.81 | 0.17 |
| 2023-06-30 | 4.56 | $32.68 | 0.14 |
| 2023-03-31 | 5.24 | $37.38 | 0.14 |
| 2022-12-31 | 5.80 | $39.00 | 0.15 |
| 2022-09-30 | 5.48 | $44.47 | 0.12 |
| 2022-06-30 | 7.40 | $50.67 | 0.15 |
| 2022-03-31 | 11.52 | $51.06 | 0.23 |
| 2021-09-30 | 31.07 | $64.43 | 0.48 |
| 2021-06-30 | 45.42 | $69.30 | 0.66 |
| 2021-03-31 | 41.67 | $61.97 | 0.67 |
| 2020-12-31 | 45.85 | $60.28 | 0.76 |
| 2020-09-30 | 49.71 | $58.25 | 0.85 |
| 2020-06-30 | 47.82 | $54.54 | 0.88 |
| 2020-03-31 | 50.76 | $54.01 | 0.94 |
| 2019-12-31 | 46.50 | $52.10 | 0.89 |
| 2019-09-30 | 38.69 | $44.86 | 0.86 |
| 2019-06-30 | 38.69 | $39.56 | 0.98 |
| 2019-03-31 | 50.64 | $37.83 | 1.34 |
| 2018-12-31 | 38.03 | $39.48 | 0.96 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.505B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.395B | 59.05 |
| Tempus AI (TEM) | United States | $14.291B | 0.00 |
| Doximity (DOCS) | United States | $11.985B | 53.33 |
| Hims & Hers Health (HIMS) | United States | $9.884B | 76.72 |
| IRhythm Technologies (IRTC) | United States | $5.815B | 0.00 |
| Hinge Health (HNGE) | United States | $3.560B | 0.00 |
| Privia Health (PRVA) | United States | $3.071B | 227.46 |
| Heartflow (HTFL) | United States | $2.895B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.406B | 39.82 |
| Enovis (ENOV) | United States | $1.800B | 9.51 |
| 10x Genomics (TXG) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.642B | 32.79 |
| Clover Health Investments (CLOV) | United States | $1.520B | 0.00 |
| Schrodinger (SDGR) | United States | $1.455B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Phreesia (PHR) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.071B | 0.00 |
| Evolent Health (EVH) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.697B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.632B | 0.00 |
| Talkspace (TALK) | United States | $0.576B | 114.67 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Standard BioTools (LAB) | United States | $0.438B | 0.00 |
| Carlsmed (CARL) | United States | $0.322B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.290B | 50.76 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.223B | 0.00 |
| Outset Medical (OM) | United States | $0.223B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.186B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 5.67 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.027B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |